How should a physician assess medication burden and polypharmacy?

References

• Eton D, Ramalho de Oliveira D, Egginton J, et al. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study. Patient Relat Outcome Meas. 2012;3:39.
   PubMedGoogle Scholar
• Gallacher K, Jani B, Morrison D, et al. Qualitative systematic reviews of treatment burden in stroke, heart failure and diabetes - Methodological challenges and solutions. BMC Med Res Methodol. 2013;13:10.
   PubMed Web of Science ®Google Scholar
• Sheehan OC, Leff B, Ritchie CS, et al. A systematic literature review of the assessment of treatment burden experienced by patients and their caregivers. BMC Geriatr. 2019;19:262.
   PubMed Web of Science ®Google Scholar
• Tran V-T, Montori VM, Eton DT, et al. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med. 2012;10:68.
   PubMed Web of Science ®Google Scholar
• Tran V-T, Harrington M, Montori VM, et al. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med. 2014;12:109.
   PubMed Web of Science ®Google Scholar
• Duncan P, Murphy M, Man M-S, et al. Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ). BMJ Open. 2018;8:e019413.
   PubMed Web of Science ®Google Scholar
• Krska J, Katusiime B, Corlett SA. Patient experiences of the burden of using medicines for long-term conditions and factors affecting burden: a cross-sectional survey. Health Soc Care Community. 2018;26:946–959.
   PubMed Web of Science ®Google Scholar
• Salisbury C, Man M-S, Bower P, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach. Lancet. 2018;392:41–50.
   PubMed Web of Science ®Google Scholar
• Eton DT, Yost KJ, Lai J, et al. Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res. 2017;26:489–503.
   PubMed Web of Science ®Google Scholar
• Ishii H, Shin H, Tosaki T, et al. Reproducibility and validity of a questionnaire measuring treatment burden on patients with Type 2 diabetes: Diabetic Treatment Burden Questionnaire (DTBQ). Diabetes Ther. 2018;9:1001–1019.
   PubMed Web of Science ®Google Scholar
• Gao L, Maidment I, Matthews F, et al. Medication usage change in older people (65+) in England over 20 years: findings from CFAS I and CFAS II. Age Ageing. 2018;47(2):220–225.
   PubMed Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17. DOI:https://doi.org/10.1186/s12877-017-0621-2
   Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995.
   PubMed Web of Science ®Google Scholar
• Nishtala PS, Salahudeen MS. Temporal trends in polypharmacy and hyperpolypharmacy in older New Zealanders over a 9-year period: 2005-2013. Gerontology. 2015;61:195–202.
   PubMed Web of Science ®Google Scholar
• Davies L, Kingston A, Todd A, et al. Characterising polypharmacy in the very old: findings from the Newcastle 85+ Study. PLoS One. 2021;16(1):e0245648.
   PubMed Web of Science ®Google Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74.
   PubMed Web of Science ®Google Scholar
• Page AT, Falster MO, Litchfield M, et al. Polypharmacy among older Australians, 2006-2017: a population-based study. Med J Aust. 2019;211(2):71–75.
   PubMed Web of Science ®Google Scholar
• Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61:83–84.
   PubMed Web of Science ®Google Scholar
• Davies LE, Spiers G, Kingston A, et al. Adverse outcomes of polypharmacy in older people: systematic review of reviews. J Am Med Dir Assoc. 2020;21:181–187.
   PubMed Web of Science ®Google Scholar
• Todd A, Jansen J, Colvin J, et al. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18:295.
   PubMed Web of Science ®Google Scholar
• Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing. 2005;34:626–632.
   PubMed Web of Science ®Google Scholar
• Wallace E, McDowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol Ser A Biol Sci Med Sci. 2017;72:271–277.
   PubMed Web of Science ®Google Scholar
• Gregory H. STOPP START toolkit supporting medication review STOPP: screening tool of older people’s potentially inappropriate prescriptions START: screening tool to alert doctors to right treatments. 2016.
   Google Scholar
• American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–694.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wong EL, Yeoh E, et al. Development of an explicit tool assessing potentially inappropriate medication use in Hong Kong elder patients. BMC Geriatr. 2021;21:98.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE. The medication appropriateness index at 20: where it started, where it has been, and where it may be going. Drugs Aging. 2013;30:893–900.
   PubMed Web of Science ®Google Scholar